Nebius Stock: A 571% Quarter, a $27 Billion Capex Bill, and the 2027 Capacity Handover That Now Does the Grading
Published on 11/17/2026 at 18:51 | Editorial boerse-global.deNebius has just delivered the kind of quarter that usually settles arguments. Revenue for the third quarter of 2026 climbed 571% year on year to $980.8 million, while adjusted EBITDA swung to a positive $465.8 million from a $5.2 million loss in the same period of 2025. Those are the numbers the company published last week — and yet the debate around the stock has not quieted. It has simply moved.
The shares were up 2.1% today, a modest rebound that says less about the results than about what investors are now being asked to weigh: not whether Nebius can grow, but whether it can convert planned data-centre capacity into billable revenue on schedule. That is a different question, and a harder one.
The operating proof is real, but it is not the whole story
There is no dismissing the scale of the swing in the core business. A year ago Nebius was posting a small adjusted loss; this quarter it produced an adjusted EBITDA figure of $465.8 million. Revenue of $980.8 million, up 571%, means the growth thesis no longer rests solely on forecasts for some distant financial year.
Adjusted EBITDA, though, is not evidence that a buildout programme pays for itself. Investors would do well to keep the operating performance and the capital plan in separate compartments. Otherwise a genuine business signal gets mistaken for an all-clear on the spending side, and the two are not the same thing.
Should investors sell immediately? Or is it worth buying Nebius?
The real pinch point sits elsewhere. Nebius must not only point to demand but turn available data-centre capacity into invoiced business. That link — between digital growth and physical construction — is where the quality of everything that follows gets decided.
Delayed third-party capacity pushes revenue into 2027
The company said last week that delays at external data-centre providers will push part of its expected revenue into 2027. For the current year, Nebius now guides toward the lower end of its existing $3.0 billion to $3.4 billion revenue range. Alongside that, it raised its capital expenditure plan to roughly $27 billion.
That pairing — a softer near-term sales outlook and a higher planned outlay — is what investors are actually trading. The investment figure is not a success metric in its own right; it has to justify itself through usable capacity and the business that capacity generates. Reuters also placed Thursday's share-price reaction in the context of a broader pullback in AI stocks and concerns about the pace of US data-centre construction, which means the Nebius discussion runs well beyond a single company forecast.
The distinction between deferred and lost revenue matters here. A timing shift is not the same as demand that has evaporated. It still changes when a growth expectation shows up in the accounts, and that is precisely what the market is repricing.
The optimistic case hangs on delivery, not on the backlog
The favourable scenario requires the deferred capacity to actually come online and then generate sales. In that reading, the delay is mainly a scheduling problem, and investors could focus on the business that follows the handover rather than on the weaker short-term trajectory.
The starting point for that view is the growth already booked. A 571% revenue increase does not prove the next expansion phase will run as smoothly, but it does show the thesis is not built entirely on future business. If the additional capacity arrives, it would attach to an already elevated revenue base.
What would strengthen this case is concrete progress on making that capacity available. Until then, the existing performance and the successful execution of the next buildout phase have to be judged separately.
A second slip would sharpen the stress test
The bearish scenario is another pushback of expected availability. The hoped-for revenue contribution would then sit even further in the future, while the raised capex plan sets the bar for execution. More money committed would wait longer for its commercial payoff.
Analyst reactions capture the tension between long-term confidence and near-term obstacles. According to media reports, one price target was cut yesterday — citing delayed data-centre capacity and the trimmed short-term revenue outlook — while the buy recommendation was kept. That combination is instructive: a positive longer-term view does not preclude a lower valuation, and an unchanged rating would not make the operational delays disappear.
Nebius at a turning point? This analysis reveals what investors need to know now.
The serious risk, then, is not only another guidance cut. It is that the gap between planned buildout and revenue-generating capacity widens once again.
2027 is the date that now carries the weight
For 2027, Nebius expects revenue of $12 billion to $13 billion. That forecast describes a substantial expansion claim, but it is not yet proof that the necessary capacity will be ready in time. To fund the buildout, the company plans investments of $40 billion to $45 billion.
So the numbers tell two stories at once. The operating business has advanced sharply; the next growth step demands an enormous deployment of capital. Both can be true simultaneously. Anyone assessing Nebius should neither downplay the earnings progress nor confuse the construction plan with business already delivered.
As long as the deferred capacity becomes available within the intended window, a later growth contribution remains a plausible scenario. Should that precondition fail, expectations for the revenue path would need revisiting again. The most reliable yardstick of progress is therefore the translation of planned capacity into revenue actually earned — and the concrete reference point is 2027, the year into which part of the expected capacity has slipped. Updates on its delivery may well matter more than further changes to price targets.
Ad
Nebius Stock: New Analysis - 17 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
